Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management
-
Published:2012-02-13
Issue:3
Volume:87
Page:284-293
-
ISSN:0361-8609
-
Container-title:American Journal of Hematology
-
language:en
-
Short-container-title:Am. J. Hematol.
Reference115 articles.
1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009
2. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008
3. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1;Tefferi;Leukemia.,2010
4. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera;Pardanani;Leukemia,2007
5. Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal;Vannucchi;Leukemia,2008
Cited by
140 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献